Palbociclib / Letrozole or Fulvestrant in African American Women With HR+ HER2- Breast Cancer
Clinical trial NCT02692755 · COMPLETED
Trial details
- NCT number
- NCT02692755
- Sponsor
- Georgetown University
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2019-12-16
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.